Anna Vihola

4.8k total citations
51 papers, 2.5k citations indexed

About

Anna Vihola is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Anna Vihola has authored 51 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 34 papers in Cardiology and Cardiovascular Medicine and 11 papers in Cell Biology. Recurrent topics in Anna Vihola's work include Muscle Physiology and Disorders (39 papers), Cardiomyopathy and Myosin Studies (33 papers) and RNA Research and Splicing (9 papers). Anna Vihola is often cited by papers focused on Muscle Physiology and Disorders (39 papers), Cardiomyopathy and Myosin Studies (33 papers) and RNA Research and Splicing (9 papers). Anna Vihola collaborates with scholars based in Finland, France and United States. Anna Vihola's co-authors include Peter Hackman, Bjarne Udd, J. Sarparanta, Bjarne Udd, Sylvie Marchand, Isabelle Richard, Isabelle Richard, Henna Haravuori, Mathias Gautel and Stephan Lange and has published in prestigious journals such as Science, Journal of Biological Chemistry and Brain.

In The Last Decade

Anna Vihola

48 papers receiving 2.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anna Vihola 2.1k 1.3k 654 444 388 51 2.5k
Marc Bitoun 1.3k 0.6× 435 0.3× 519 0.8× 1.1k 2.5× 215 0.6× 64 2.1k
Anna Fidziańska 1.8k 0.9× 802 0.6× 382 0.6× 347 0.8× 481 1.2× 121 2.3k
Homa Tajsharghi 1.2k 0.6× 875 0.7× 193 0.3× 152 0.3× 544 1.4× 54 1.5k
Rita Barresi 1.8k 0.9× 542 0.4× 451 0.7× 497 1.1× 239 0.6× 36 2.1k
Belinda S. Cowling 1.3k 0.6× 481 0.4× 383 0.6× 807 1.8× 239 0.6× 48 1.8k
Louise V.B. Anderson 2.7k 1.3× 600 0.5× 844 1.3× 773 1.7× 311 0.8× 53 3.0k
C. Jimenez‐Mallebrera 1.5k 0.7× 273 0.2× 256 0.4× 303 0.7× 295 0.8× 78 1.9k
Rafaëlle Bernard 2.3k 1.1× 237 0.2× 354 0.5× 367 0.8× 274 0.7× 54 2.8k
Marco Savarese 983 0.5× 477 0.4× 224 0.3× 166 0.4× 271 0.7× 72 1.3k
Nathalie Bourg 2.7k 1.3× 548 0.4× 943 1.4× 1.2k 2.7× 235 0.6× 34 3.1k

Countries citing papers authored by Anna Vihola

Since Specialization
Citations

This map shows the geographic impact of Anna Vihola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Vihola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Vihola more than expected).

Fields of papers citing papers by Anna Vihola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Vihola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Vihola. The network helps show where Anna Vihola may publish in the future.

Co-authorship network of co-authors of Anna Vihola

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Vihola. A scholar is included among the top collaborators of Anna Vihola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Vihola. Anna Vihola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jokela, Manu, Sanna Huovinen, Cornelia Kornblum, et al.. (2025). Characterization of novel CASQ1 variants in two families with unusual phenotypic features. Journal of Neurology. 272(12). 789–789.
2.
Claeys, Kristl G., Marco Savarese, Per Harald Jonson, et al.. (2024). A Titin Truncating Variant Causing a Dominant Myopathy With Cardiac Involvement in a Large Family. Neurology Genetics. 10(5). e200185–e200185.
3.
Palmio, Johanna, Manu Jokela, Päivi Hartikainen, et al.. (2023). CACNA1S Variant Associated With a Myalgic Myopathy Phenotype. Neurology. 101(18). e1779–e1786. 6 indexed citations
4.
Sarparanta, J., Per Harald Jonson, Jens Reimann, et al.. (2023). Extension of the DNAJB2a isoform in a dominant neuromyopathy family. Human Molecular Genetics. 32(21). 3029–3039. 4 indexed citations
5.
Johari, Mridul, Anna Vihola, Johanna Palmio, et al.. (2022). Comprehensive transcriptomic analysis shows disturbed calcium homeostasis and deregulation of T lymphocyte apoptosis in inclusion body myositis. Journal of Neurology. 269(8). 4161–4173. 14 indexed citations
6.
Savarese, Marco, Anna Vihola, Manu Jokela, et al.. (2021). Out-of-Frame Mutations in ACTN2 Last Exon Cause a Dominant Distal Myopathy With Facial Weakness. Neurology Genetics. 7(5). e619–e619. 7 indexed citations
7.
Jokela, Manu, Giorgio Tasca, Anna Vihola, et al.. (2019). An unusual ryanodine receptor 1 (RYR1) phenotype. Neurology. 92(14). e1600–e1609. 12 indexed citations
8.
Savarese, Marco, Johanna Palmio, Juan José Poza, et al.. (2019). Actininopathy: A new muscular dystrophy caused by ACTN2 dominant mutations. Annals of Neurology. 85(6). 899–906. 26 indexed citations
9.
Palmio, Johanna, Per Harald Jonson, Michio Inoue, et al.. (2019). Mutations in the J domain of DNAJB6 cause dominant distal myopathy. Neuromuscular Disorders. 30(1). 38–46. 22 indexed citations
10.
Savarese, Marco, J. Sarparanta, Anna Vihola, Bjarne Udd, & Peter Hackman. (2016). Increasing Role of Titin Mutations in Neuromuscular Disorders. Journal of Neuromuscular Diseases. 3(3). 293–308. 97 indexed citations
11.
Evilä, Anni, Johanna Palmio, Anna Vihola, et al.. (2016). Targeted Next-Generation Sequencing Reveals Novel TTN Mutations Causing Recessive Distal Titinopathy. Molecular Neurobiology. 54(9). 7212–7223. 29 indexed citations
12.
Dabby, Ron, Menachem Sadeh, David Hilton‐Jones, et al.. (2015). Adult onset limb-girdle muscular dystrophy — A recessive titinopathy masquerading as myositis. Journal of the Neurological Sciences. 351(1-2). 120–123. 14 indexed citations
13.
14.
Charton, Karine, Nathalie Danièle, Anna Vihola, et al.. (2010). Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies. Human Molecular Genetics. 19(23). 4608–4624. 30 indexed citations
15.
Raheem, Olayinka, Shodimu-Emmanuel Olufemi, Linda L. Bachinski, et al.. (2010). Mutant (CCTG)n Expansion Causes Abnormal Expression of Zinc Finger Protein 9 (ZNF9) in Myotonic Dystrophy Type 2. American Journal Of Pathology. 177(6). 3025–3036. 61 indexed citations
16.
Vihola, Anna, Mario Sirito, Linda L. Bachinski, et al.. (2007). G.P.14.14 Differences in aberrant expression and splicing of genes involved in Ca2+ metabolism between myotonic dystrophy type 2 (DM2) and type 1 (DM1). Neuromuscular Disorders. 17(9-10). 858–858. 1 indexed citations
17.
Lange, Stephan, Fengqing Xiang, Anna Vihola, et al.. (2005). The Kinase Domain of Titin Controls Muscle Gene Expression and Protein Turnover. Science. 308(5728). 1599–1603. 454 indexed citations
18.
Sallinen, Riitta, Anna Vihola, Linda L. Bachinski, et al.. (2004). New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2). Neuromuscular Disorders. 14(4). 274–283. 37 indexed citations
19.
Vihola, Anna, et al.. (2003). The role of titin in muscular disorders. Annals of Medicine. 35(6). 434–441. 28 indexed citations
20.
Hackman, Peter, Anna Vihola, Henna Haravuori, et al.. (2002). Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin. The American Journal of Human Genetics. 71(3). 492–500. 310 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Bitoun Breakdown of academic impact, for papers by Anna Fidziańska Breakdown of academic impact, for papers by Homa Tajsharghi Breakdown of academic impact, for papers by Rita Barresi Breakdown of academic impact, for papers by Belinda S. Cowling Breakdown of academic impact, for papers by Louise V.B. Anderson Breakdown of academic impact, for papers by C. Jimenez‐Mallebrera Breakdown of academic impact, for papers by Rafaëlle Bernard Breakdown of academic impact, for papers by Marco Savarese Breakdown of academic impact, for papers by Nathalie Bourg
Rankless by CCL
2026